Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
Clinical data to date shows efti uniquely positioned to address entire NSCLC patient population through both chemo-free IO-IO and IO-IO-chemo triple combinations
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
Proposed combination enhances Pfizer’s position as a leading company in oncology
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
Subscribe To Our Newsletter & Stay Updated
